Synthetic vaccine for immunotherapy of androgen-sensitive prostate cancer(Zhuhai United Laboratories)

ๅ…็–ซๆฒป็–—้›„ๆฟ€็ด ๆ•ๆ„Ÿๆ€งๅ‰ๅˆ—่…บ็™Œๅˆๆˆ็–ซ่‹—๏ผˆ็ ๆตท่”้‚ฆๅˆถ่ฏ๏ผ‰

Report date: 2025/06/26 16:29:53

Base Information

Drug NameSynthetic vaccine for immunotherapy of androgen-sensitive prostate cancer(Zhuhai United Laboratories)
Drug Alias Name้›„ๆฟ€็ด ๆ•ๆ„Ÿๆ€งๅ‰ๅˆ—่…บ็™Œ็–ซ่‹— - ็ ๆตท่”้‚ฆๅˆถ่ฏ
ClassificationVaccines > Application > Therapeutic vaccineCell and gene therapy > Cell therapy > Immune system cell therapy
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHormone-Sensitive Prostate Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusDiscontinued (Clinical)
Highest Status in ChinaDiscontinued
Originator CompaniesZhongshan Branch of Zhuhai United Laboratories Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesN/A
Inactive CompaniesZhongshan Branch of Zhuhai United Laboratories Co Ltd
Active IndicationsN/A
Inactive IndicationsHormone-Sensitive Prostate Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A